methylmalonic acid has been researched along with transforming growth factor beta in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ahmed, A; Asara, J; Blenis, J; Broekaert, D; Cantley, LC; de Cabo, R; Dephoure, N; Elia, I; Endress, JE; Fendt, SM; Fernández-García, J; Gomes, AP; Han, J; Ilter, D; Kinzig, C; Low, V; Mullarky, E; Mutvei, AP; Planque, M; Rosenzweig, A; Schild, T | 1 |
Blenis, J; Cantley, LC; Cho, S; Dephoure, N; Earlie, E; Endress, J; Guo, C; Hu, M; Jin, W; Laughney, AM; Li, Z; Low, V; Luga, V; Lyden, D; Parang, B; Schild, T; Shobana Ganesh, K; Sun, J | 1 |
2 other study(ies) available for methylmalonic acid and transforming growth factor beta
Article | Year |
---|---|
Age-induced accumulation of methylmalonic acid promotes tumour progression.
Topics: Adult; Aged; Aging; Animals; Cell Line, Tumor; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Methylmalonic Acid; Mice; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Signal Transduction; SOXC Transcription Factors; Transcriptome; Transforming Growth Factor beta | 2020 |
Tumor-produced and aging-associated oncometabolite methylmalonic acid promotes cancer-associated fibroblast activation to drive metastatic progression.
Topics: Cancer-Associated Fibroblasts; Extracellular Vesicles; Humans; Interleukin-6; Methylmalonic Acid; Neoplasms; Reactive Oxygen Species; Transforming Growth Factor beta; Tumor Microenvironment | 2022 |